Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Resiquimod Sulfate (usan)
2. 2762439-40-5
3. Resiquimod Sulfate [usan]
4. Eik1001 Sulfate
5. Eik-1001 Sulfate
6. C8fkis4p1n
7. Bdb001
8. Bdb 001 [who-dd]
9. Bdb-001
10. C151008135d
11. C151008135-d
12. D13051
13. 4-amino-2-(ethoxymethyl)-1-(2-hydroxisobutyl) Imidazo[4,5-c]quinoline, Sulfate (1:1)
14. 1h-imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-, Sulfate (1:1)
| Molecular Weight | 412.5 g/mol |
|---|---|
| Molecular Formula | C17H24N4O6S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 169 |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 487 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
BDB-001 is an anti-C5RA1 monoclonal antibody activating the toll-like receptor. It has potential antineoplastic and immunostimulating activities.
ABOUT THIS PAGE
21
PharmaCompass offers a list of Resiquimod Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Resiquimod Sulfate manufacturer or Resiquimod Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Resiquimod Sulfate manufacturer or Resiquimod Sulfate supplier.
A Resiquimod Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Resiquimod Sulfate, including repackagers and relabelers. The FDA regulates Resiquimod Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Resiquimod Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Resiquimod Sulfate supplier is an individual or a company that provides Resiquimod Sulfate active pharmaceutical ingredient (API) or Resiquimod Sulfate finished formulations upon request. The Resiquimod Sulfate suppliers may include Resiquimod Sulfate API manufacturers, exporters, distributors and traders.
Resiquimod Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Resiquimod Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Resiquimod Sulfate GMP manufacturer or Resiquimod Sulfate GMP API supplier for your needs.
A Resiquimod Sulfate CoA (Certificate of Analysis) is a formal document that attests to Resiquimod Sulfate's compliance with Resiquimod Sulfate specifications and serves as a tool for batch-level quality control.
Resiquimod Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Resiquimod Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Resiquimod Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Resiquimod Sulfate EP), Resiquimod Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Resiquimod Sulfate USP).
